Who has invested in Vita Therapeutics?

Early Light Ventures, Kiwi Bio, SEM Life Science are named among the investors backing Vita Therapeutics.

Vita Therapeutics Funding: $35M Raised, Series A (2024)

Vita Therapeutics funding overview

Vita Therapeutics is based in Baltimore, Country. Vita Therapeutics has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Vita Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Early Light Ventures, Kiwi Bio, SEM Life Science. 3 distinct backers are named across the disclosed rounds.

Vita Therapeutics at a glance

Total raised: $35M
Latest round: Series A
Latest round date: January 2024
Headquarters: Baltimore, Country
Notable investors: Early Light Ventures, Kiwi Bio, SEM Life Science

Frequently asked about Vita Therapeutics funding

How much has Vita Therapeutics raised?: Vita Therapeutics has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Vita Therapeutics?: Early Light Ventures, Kiwi Bio, SEM Life Science are named among the investors backing Vita Therapeutics.
What was the latest Vita Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2024.
Where is Vita Therapeutics based?: Vita Therapeutics is based in Baltimore, Country.
When did Vita Therapeutics last raise?: The last disclosed Vita Therapeutics round closed in January 2024 at Series A.

Round data for Vita Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Baltimore and backer lists below.

Vita Therapeutics Funding: $35M Raised, Series A (2024)

Vita Therapeutics funding overview

Vita Therapeutics at a glance

Frequently asked about Vita Therapeutics funding

Companies related to Vita Therapeutics (19)

Browse related funding lists (3)